Merck CEO sees a disintermediation in pharma like the cable industry

Kenneth Frazier, the CEO of pharma giant Merck (MRK), sees the possibility of a disintermediation in the pharmaceutical industry that can make drugs more affordable.

Speaking at the Economic Club of New York on Wednesday, Frazier said that one thing that the Trump administration is focused on is breaking down some of the opacity in the health care system by looking at the participants, their roles, and the relative value that they bring.